UK markets open in 4 hours 42 minutes

Evaxion Biotech A/S (EVAX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.1300-0.0100 (-0.24%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
73
73
0
0
0
Operating expenses
Research development
11,916
11,916
17,056
19,583
10,902
Selling general and administrative
10,079
10,079
8,064
6,180
5,654
Total operating expenses
22,270
22,270
25,264
25,834
16,568
Operating income or loss
-22,197
-22,197
-25,264
-25,834
-16,568
Interest expense
897
897
798
159
29
Total other income/expenses net
25
25
2,108
1,283
22
Income before tax
-22,915
-22,915
-23,941
-24,710
-16,575
Income tax expense
-790
-790
-772
-178
-1,557
Income from continuing operations
-22,125
-22,125
-23,169
-24,532
-15,018
Net income
-22,125
-22,125
-23,169
-24,532
-15,018
Net income available to common shareholders
-22,125
-22,125
-23,169
-24,532
-15,018
Basic EPS
-9.50
-
-9.80
-12.60
-9.27
Diluted EPS
-9.50
-
-9.80
-12.60
-9.27
Basic average shares
2,609
-
2,364
1,949
1,620
Diluted average shares
2,609
-
2,364
1,949
1,620